Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorPOISNEL, G.
dc.contributor.authorARENAZA-URQUIJO, E.
dc.contributor.authorCOLLETTE, F.
dc.contributor.authorKLIMECKI, O. M.
dc.contributor.authorMARCHANT, N. L.
dc.contributor.authorWIRTH, M.
dc.contributor.authorDE LA SAYETTE, V.
dc.contributor.authorRAUCHS, G.
dc.contributor.authorSALMON, E.
dc.contributor.authorVUILLEUMIER, P.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorFRISON, Éric
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMAILLARD, Aline
dc.contributor.authorVIVIEN, D.
dc.contributor.authorLUTZ, A.
dc.contributor.authorCHETELAT, G.
dc.date.accessioned2020-12-14T15:34:26Z
dc.date.available2020-12-14T15:34:26Z
dc.date.issued2018-12-26
dc.identifier.issn2352-8737en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/21456
dc.description.abstractEnIntroduction: The Age-Well clinical trial is an ongoing monocentric, randomized, controlled trial aiming to assess an 18-month preventive meditation-based intervention directly targeting the attentional and emotional dimensions of aging to promote mental health and well-being in elderly people. Methods: One hundred thirty-seven cognitively unimpaired older adults are randomized to either an 18-month meditation-based intervention, a structurally matched foreign language training, or a passive control arm. The impact of the intervention and underlying mechanisms are assessed with detailed cognitive, behavioral, biological, neuroimaging and sleep examinations. Results: Recruitment began in late 2016 and ended in May 2018. The interventions are ongoing and will be completed by early 2020. Discussion: This is the first trial addressing the emotional and cognitive dimension of aging with a long-term nonpharmacological approach and using comprehensive assessments to investigate the mechanisms. Results are expected to foster the development of preventive strategies reducing the negative impact of mental conditions and disorders.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subject.enUSMR
dc.subject.enEUCLID
dc.subject.enF-CRIN
dc.title.enThe Age-Well randomized controlled trial of the Medit-Ageing European project: Effect of meditation or foreign language training on brain and mental health in older adults
dc.title.alternativeAlzheimers Dementen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.trci.2018.10.011en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed30581977en_US
bordeaux.journalAlzheimer's & dementia (New York, N. Y.)en_US
bordeaux.page714-723en_US
bordeaux.volume4en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamUSMRen_US
bordeaux.teamEUCLIDen_US
bordeaux.teamHEALTHY_BPH
bordeaux.teamF-CRINen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Alzheimer's%20&%20dementia%20(New%20York,%20N.%20Y.)&rft.date=2018-12-26&rft.volume=4&rft.spage=714-723&rft.epage=714-723&rft.eissn=2352-8737&rft.issn=2352-8737&rft.au=POISNEL,%20G.&ARENAZA-URQUIJO,%20E.&COLLETTE,%20F.&KLIMECKI,%20O.%20M.&MARCHANT,%20N.%20L.&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée